RET and neoplasm: In Ba/F3-KIF5B-RET-G810S xenograft model, BYS10 (1 mg/kg), 10 times less than the dose of Selpercatinib (10 mg/kg), obviously inhibited tumor growth, with TGI value of 78.29%.